Thelansis

Osteoarthritis (OA) Market Outlook Thelansis’s “Osteoarthritis (OA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Osteoarthritis (OA) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What...

Osteoarthritis (OA) Market Outlook Thelansis’s “Osteoarthritis (OA)   Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Osteoarthritis (OA)   treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Osteoarthritis (OA) Overview Osteoarthritis (OA) is a complex condition characterized by progressive musculoskeletal pain and restricted movement, often accompanied by the deterioration of articular cartilage, changes in local bone structure, and the development of osteophytes. This joint disorder manifests differently between men and women, highlighting the importance of recognizing gender dimorphism for both prevention and treatment str...

  Osteoarthritis (OA) is a multifactorial disease process whereby progressive musculoskeletal pain and limitation in the movement are accompanied by the loss of articular cartilage, sclerotic and cystic changes in local bone, and osteophyte formation. OA is a joint condition whose presentation so differs between men and women in its attributes that both prevention activities and treatment would benefit from recognition of this dimorphism. These structural and anatomic differences between the sexes are observed early and later in life. Articular cartilage of the distal femur is less thick in girls and women than in boys and men—pain in the affected joint, including thickening of the joint capsule and the formation of osteophytes. ~43.3% have pain, aching, or stiffness osteoarthritis on most days. Reports of pain increased with age up to 68% of patients and were higher in blacks than in whites and in women than in men, 47.6% and 37.4%, respectively.   In the US, the total pr...